Space bugs for blood testing — and more

August 17, 2012
Space bugs for blood testing—and more
Space bugs prototypes.

Thanks to ideas of putting swarms of tiny robot bugs to work on a future space station, patients being medicated for blood clots may soon get a simple, home-use testing kit, here on Earth.

Fifteen years ago as a graduate student, Vladislav Djakov started building these micro-electromechanical creatures that mimic the of bugs found in nature.

Equipped with a , limited intelligence and , the bugs would be small enough to send en masse to hard-to-reach places, like pipes carrying on space stations.

There, monitoring changes in temperature or flow could warn of impending malfunctions.

To move the bugs, the hit on using cilia-like motion, much like some deep-sea creatures use to propel themselves. They covered one face of the with tiny cantilever arms.

“They would then move along on these like millipedes,” said Dr Djakov, now Director of Sensor Development at Microvisk Technologies.

In the end, the space bugs were ahead of their time: they haven’t yet progressed past the testing phase.

But the cilia approach – the cantilever arms to propel the bugs – has gone further.

Space cantilevers spin off

Space bugs for blood testing—and more
Microvisk’s microchip.

STFC Innovation, ESA’s Technology Transfer Programme partner that operates the agency’s Business Incubation Centre Harwell in the UK, saw the business potential in the medical market and supported start-up company Microvisk to spin off the technology.

At Microvisk, Dr Djakov’s team stripped down the microchips and put the intelligent sensing mechanisms right into the cantilever arms, almost like a cat’s whiskers.

Space bugs for blood testing—and more
CoagLite with test strips.

 

These whiskers turned out to be very good at monitoring liquids. Sweeping through, they note changes in viscosity and register if anything is suspended in the liquid.

“This is very interesting for probing , plasma, and other bodily fluids,” said Dr Djakov.

At present, investors are betting on a device to monitor blood coagulation for patients taking blood thinner medication: “It’s like a diabetes test, but for thrombosis.”

Thanks to this coagulometer, the Microvisk CoagLite, patients will soon be able to test themselves at home with the prick of a finger.

After a small chamber inside the test strip fills with blood, the tiny cantilever sweeps the drop, monitoring how quickly it coagulates.

“You need less blood, which means there is less pain,” said Dr Djakov, who compared its ease-of-use to diabetics’ simple glucose monitors. “Haematologists are finding it really important.”

Now undergoing clinical testing with US Food and Drug Administration, the coagulometer should be on the market later next year.

But the whisker technology isn’t limited to testing blood.

“It would be good for things like plasma or teardrops,” said Dr Djakov, “or to test the oil in a car engine, or in the food industry, to test chocolate or ketchup.

“There are literally hundreds of applications, for this innovation which started as a ‘space bug’.”  

Explore further: Spinning blood device set to safeguard astronaut health

Related Stories

Spinning blood device set to safeguard astronaut health

November 14, 2011
(PhysOrg.com) -- ESA has begun developing a new blood-testing device for astronauts on the International Space Station. A wide range of ailments from diabetes to heart disease should be diagnosable in moments from a single ...

For diabetics not on insulin, self-monitoring blood sugar has no benefit

January 20, 2012
For type 2 diabetics who are not on insulin, monitoring their blood sugar does little to control blood sugar levels over time and may not be worth the effort or expense, according to a new evidence review.

Bed bugs with MRSA superbug superbad news: expert

May 16, 2011
As if the recent resurgence of bed bugs wasn’t bad enough, Canadian researchers have found some of the little blood-sucking critters carrying methicillin-resistant Staphylococcus aureus, the potentially deadly superbug ...

Recommended for you

Groundbreaking investigative effort identifies gonorrhea vaccine candidates

September 19, 2017
Researchers at Oregon State University have identified a pair of proteins that show promise as the basis for a gonorrhea vaccine.

Snail fever progression linked to nitric oxide production

September 14, 2017
Bilharzia, caused by a parasitic worm found in freshwater called Schistosoma, infects around 200 million people globally and its advance can lead to death, especially in children in developing countries.

Systems analysis points to links between Toxoplasma infection and common brain diseases

September 13, 2017
More than 2 billion people - nearly one out of every three humans on earth, including about 60 million people in the United States - have a lifelong infection with the brain-dwelling parasite Toxoplasma gondii.

Study clears important hurdle toward developing an HIV vaccine

September 13, 2017
An international team of researchers has demonstrated a way of overcoming one of the major stumbling blocks that has prevented the development of a vaccine against HIV: the ability to generate immune cells that stay in circulation ...

As 'flesh-eating' Leishmania come closer, a vaccine against them does, too

September 13, 2017
Parasites that ulcerate the skin, can disfigure the face, and may fatally mutilate its victim's internal organs are creeping closer to the southern edges of the United States.

Promising clinical trial results could give doctors a new tool against drug-resistant strains of malaria parasite

September 13, 2017
Tulane University researchers have developed a new drug that is effective against non-severe cases of malaria, according to results from an FDA-supervised clinical trial published in the latest issue of The Lancet Infectious ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.